Exploratory Study Investigating Urodynamic Parameters During Catheterisation
1 other identifier
interventional
30
1 country
1
Brief Summary
The objective of the study is to explore and understand how urodynamic parameters are affected when emptying the bladder with an intermittent catheter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedStudy Start
First participant enrolled
November 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2018
CompletedResults Posted
Study results publicly available
August 12, 2024
CompletedAugust 12, 2024
March 1, 2024
6 months
November 7, 2017
January 31, 2020
March 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Discomfort During Catheter Insertion on a Visual Analogue Scale
On a scale ranging from 0 "no discomfort" to 10 "worst possible discomfort" caused by the catheter, set a vertical line indicating how you experienced the insertion of the catheter. Higher scores mean a worse outcome.
Filled out after 5 minutes per catheterisation.
Study Arms (1)
Measurement of endpoints
EXPERIMENTALIn healthy volunteers the endpoint are measured while spontaneous voiding of the bladder and while emptying the bladder using a standard intermittent catheter. In subjects with spinal cord injury or enlarged prostata the endpoint are measured while emptying the bladder using a standard intermittent catheter.
Interventions
SpeediCath is a standard intermittent catheter that is on the market.
Eligibility Criteria
You may qualify if:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Be male
- For healthy volunteers: Willing to comply with not using analgesics up to 24 hours prior to study visit
- For healthy volunteers: Negative urine multistix (leukocytes and nitrite), or if positive, subsequent negative for bacterial growth in urine culture
- For SCI and BPH patients: Use intermittent catheter daily and have used intermittent catheters for at least 2 months
You may not qualify if:
- Symptoms of urinary tract infections (frequent urination, stinging and pain at urination)
- For healthy volunteers: Abnormalities, diseases or surgical procedures performed in the lower urinary tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Department of Urology, Rigshospitalet
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Vice President, Medical Affairs
- Organization
- Coloplast A/S
Study Officials
- STUDY DIRECTOR
Nazarena Mazarro
Vice president Medical Affairs
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2017
First Posted
November 8, 2017
Study Start
November 30, 2017
Primary Completion
May 29, 2018
Study Completion
May 29, 2018
Last Updated
August 12, 2024
Results First Posted
August 12, 2024
Record last verified: 2024-03